The primary objective was To guage the efficacy with the vaccine compared to placebo in cutting down cocaine use. Secondary aims integrated confirming vaccine immunogenicity by means of IgG anti-cocaine antibody concentrations and assessing the security and tolerability of vaccination via a 20 week review and at 24 week stick https://herodotush528hui1.theideasblog.com/profile